Andrew Ratz

Chief Tech/Sci/R&D Officer at NEUROCRINE BIOSCIENCES, INC.

Net worth: 171 569 $ as of 30/06/2026

Health Technology

Consumer Services

Profile

Dr. Andrew Ratz is a Chief Technical Operations Officer at Neurocrine Biosciences, Inc. Dr. Ratz was previously employed as a Senior Vice President & Head-Drug Delivery by Eli Lilly & Co. He received his undergraduate degree from Indiana University and a doctorate degree from Harvard University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
NEUROCRINE BIOSCIENCES, INC. 0%	15/03/2026	1,018 ( 0% )	171 569 $	30/06/2026

Andrew Ratz active positions

Companies	Position	Start
NEUROCRINE BIOSCIENCES, INC.	Chief Tech/Sci/R&D Officer	17/03/2026

All active positions of Andrew Ratz

Former positions of Andrew Ratz

Companies	Position	End
ELI LILLY AND COMPANY	Corporate Officer/Principal	-

See the detail of Andrew Ratz's experience

Training of Andrew Ratz

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andrew Ratz's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Eli Lilly & Co. Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products	Health Technology
Neurocrine Biosciences, Inc. Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders	Health Technology
Harvard University Harvard University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Indiana University Indiana University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services